Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
Saved in:
| Title: | Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. |
|---|---|
| Authors: | He M; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Jiang YZ; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Gong Y; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Fan L; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu XY; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu Y; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Tang LC; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Mo M; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Cancer Prevention and Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, China., Hou YF; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Di GH; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Liu GY; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Yu KD; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Wu J; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Yan X; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Zeng XH; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China., Fu DY; Department of Thyroid and Breast Surgery, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China., Song CG; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China., Zhuang ZG; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Shanghai Tongji University, Shanghai, China., Wu KJ; Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China., Wang J; Department of Breast Surgery, The International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiao Tong University, Shanghai, China., Wang ZH; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China., Shao ZM; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China zhimingshao@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. |
| Source: | BMJ (Clinical research ed.) [BMJ] 2024 Oct 23; Vol. 387, pp. e079603. Date of Electronic Publication: 2024 Oct 23. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39442958 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22He+M%22">He M</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Jiang+YZ%22">Jiang YZ</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Gong+Y%22">Gong Y</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Fan+L%22">Fan L</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+XY%22">Liu XY</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Tang+LC%22">Tang LC</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Mo+M%22">Mo M</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Cancer Prevention and Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Hou+YF%22">Hou YF</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Di+GH%22">Di GH</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+GY%22">Liu GY</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yu+KD%22">Yu KD</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Yan+X%22">Yan X</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zeng+XH%22">Zeng XH</searchLink>; Breast Center, Chongqing Cancer Hospital, Chongqing University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Fu+DY%22">Fu DY</searchLink>; Department of Thyroid and Breast Surgery, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Song+CG%22">Song CG</searchLink>; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+ZG%22">Zhuang ZG</searchLink>; Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Shanghai Tongji University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wu+KJ%22">Wu KJ</searchLink>; Department of Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Breast Surgery, The International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiao Tong University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+ZH%22">Wang ZH</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Shao+ZM%22">Shao ZM</searchLink>; Department of Breast Surgery, Fudan University Shanghai Cancer and Key Laboratory of Breast Cancer in Shanghai, Shanghai, China zhimingshao@fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228900488%22">BMJ (Clinical research ed.)</searchLink> [BMJ] 2024 Oct 23; Vol. 387, pp. e079603. <i>Date of Electronic Publication: </i>2024 Oct 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22British+Medical+Association%22">British Medical Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8900488 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-1833 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598138%22">09598138 </searchLink><i>NLM ISO Abbreviation: </i>BMJ <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39442958 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bmj-2024-079603 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e079603 Titles: – TitleFull: Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: He M – PersonEntity: Name: NameFull: Jiang YZ – PersonEntity: Name: NameFull: Gong Y – PersonEntity: Name: NameFull: Fan L – PersonEntity: Name: NameFull: Liu XY – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Tang LC – PersonEntity: Name: NameFull: Mo M – PersonEntity: Name: NameFull: Hou YF – PersonEntity: Name: NameFull: Di GH – PersonEntity: Name: NameFull: Liu GY – PersonEntity: Name: NameFull: Yu KD – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Yan X – PersonEntity: Name: NameFull: Zeng XH – PersonEntity: Name: NameFull: Fu DY – PersonEntity: Name: NameFull: Song CG – PersonEntity: Name: NameFull: Zhuang ZG – PersonEntity: Name: NameFull: Wu KJ – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Wang ZH – PersonEntity: Name: NameFull: Shao ZM IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 10 Text: 2024 Oct 23 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1756-1833 Numbering: – Type: volume Value: 387 Titles: – TitleFull: BMJ (Clinical research ed.) Type: main |
| ResultId | 1 |
